Clinical Trials Browser

OTHER × HER2 × disitamab vedotin × Clear all

NCT05649163 2022-12-16

Real-world Study of HER2-overexpressed Advanced Solid Tumors After Progression of First-line Standard Therapy

GastrointestinalOther solid neoplasm

HER2